Annovis Bio Inc.
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Open-label Long-term Safety Study of Buntanetap in Participants With AD (NCT07757204) | Annovis Bio Inc. | 2026-09-21 |
| A Study of Buntanetap in Participants With PD (NCT07284784) | Annovis Bio Inc. | 2026-01-09 |
| A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD (NCT06709014) | Annovis Bio Inc. | 2025-02-04 |
| A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD (NCT05686044) | Annovis Bio Inc. | 2023-04-01 |
| A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD (NCT05357989) | Annovis Bio Inc. | 2022-08-03 |
| Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients (NCT04524351) | Annovis Bio Inc. | 2020-08-14 |
Track Annovis Bio Inc. automatically
Every clearance here is in the API, with alerts when new ones post.